Concepedia

Shruthi Vaidhyanathan

SV

Statistics

Publications

9

Citations

612

H-Index

9

Active since

2012

Affiliations

University of Minnesota(Current)

Mayo Clinic

Janssen (Belgium)

Sanofi (United States)

Simulations Plus (United States)

Shruthi Vaidhyanathan is an author at University of Minnesota specializing in medicine, radiation oncology, and pharmacology.

Top concepts

Publications per year

2012–2023

9

Publications

9

Mechanisms Limiting Distribution of the Threonine-Protein Kinase B-RaFV600E Inhibitor Dabrafenib to the Brain: Implications for the Treatment of Melanoma Brain Metastases

Rajendar K. Mittapalli, Shruthi Vaidhyanathan, Arkadiusz Z. Dudek et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 175 citations · Full text

Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on the Brain Distribution of a Novel BRAF Inhibitor: Vemurafenib (PLX4032)

Rajendar K. Mittapalli, Shruthi Vaidhyanathan, Ramola Sane et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 162 citations · Full text

Factors Influencing the CNS Distribution of a Novel MEK-1/2 Inhibitor: Implications for Combination Therapy for Melanoma Brain Metastases

Shruthi Vaidhyanathan, Rajendar K. Mittapalli, Jann N. Sarkaria et al. · Drug Metabolism and Disposition · 2014 · 102 citations · Full text

Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?

Gautham Gampa, Shruthi Vaidhyanathan, Jann N. Sarkaria et al. · Pharmacological Research · 2017 · 46 citations · Full text

, , +10

Bioequivalence Comparison of Pediatric Dasatinib Formulations and Elucidation of Absorption Mechanisms Through Integrated PBPK Modeling

Shruthi Vaidhyanathan, Xiaoning Wang, John R. Crison et al. · Journal of Pharmaceutical Sciences · 2018 · 42 citations

, , +10

1–5 of 9